Purdue Pharma pleas could bolster efforts for Canadian opioid class action
TORONTO — A Canadian class action against opioid makers will start the process of getting certified in a hearing next month, a key test on how courts here will handle a case that is making waves in the U.S. The upcoming hearing in Quebec comes after this week’s news that Purdue Pharma, the company behind […]
Read more »